Global Pediatric Vaccines Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

Global Pediatric Vaccines Market Overview:

“The global Pediatric Vaccines Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”

Pediatric vaccine helps infant, children to develop immune system to fight against serious infections and diseases. It is given to children with an age group of 0-18 years. Vaccination starts from early stage of life which helps children to protect from several infectious diseases. Pediatric vaccination has made many serious childhood diseases rare. Rotavirus causes diarrhea in children, the rotavirus vaccine project against rotavirus.

Increasing awareness about the benefits associated with vaccination in preventing diseases globally is expected to fuel the growth of global pediatric vaccines market over the forecast period. Moreover, several government and non-profit organizations providing education, funding and support services for vaccines is anticipated to further drive growth of the global pediatric vaccines market over the forecast period. Increasing number of cases of influenza, hepatitis, bacterial and viral infection in infant, children and increasing birth rate globally is expected to fuel the market demand over the forecast period.

Stringent government regulations for approval process and high cost involved with the development of vaccines are major factor restraining the growth of pediatric vaccines market over the forecast period.

However, technological advancements and innovations focusing on development of pediatric vaccines with high efficiency and low cost is expected to create new opportunities for existing as well as new market entrant in the global pediatric vaccines market over the forecast period.

North America market dominates the global pediatric vaccines market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of well-developed healthcare infrastructure and presence of dominant players in the region. Europe accounts for second-largest revenue share contribution to the global pediatric vaccines market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Europe is projected to register comparatively faster growth in terms of revenue over the next 10 years owing increasing incidence of diseases such hepatitis, pneumococcal disease, and influenza in the region.

Global pediatric vaccines market segmentation

By vaccine type:

• Monovalent Vaccines
• Multivalent Vaccines

By technique:

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Recombinant Vector Vaccine

By Disease:

• Measles, Mumps, and rubella (MMR)
• Pneumococcal disease
• Meningococcal disease
• Influenza
• Diphtheria, Tetanus, and Pertussis (DTP)
• Hepatitis
• Chickenpox
• Rotavirus

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa